Chemoinformaics analysis of Dimethyltryptamine methiodide
| Molecular Weight | 330.213 | nRot | 3 |
| Heavy Atom Molecular Weight | 311.061 | nRig | 10 |
| Exact Molecular Weight | 330.059 | nRing | 2 |
| Solubility: LogS | 0.737 | nHRing | 1 |
| Solubility: LogP | -0.408 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 10 |
| nHA | 0 | APOL | 41.9291 |
| nHD | 1 | BPOL | 21.9109 |
| QED | 0.737 |
| Synth | 2.278 |
| Natural Product Likeliness | 0.45 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.993 |
| HIA | 0.871 |
| CACO-2 | -5.366 |
| MDCK | 0.00000541 |
| BBB | 0.313 |
| PPB | 0.296529 |
| VDSS | 1.359 |
| FU | 0.639706 |
| CYP1A2-inh | 0.048 |
| CYP1A2-sub | 0.974 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.705 |
| CYP2d6-inh | 0.057 |
| CYP2d6-sub | 0.943 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.116 |
| CL | 4.944 |
| T12 | 0.948 |
| hERG | 0.058 |
| Ames | 0.012 |
| ROA | 0.805 |
| SkinSen | 0.128 |
| Carcinogencity | 0.037 |
| EI | 0.15 |
| Respiratory | 0.959 |
| NR-Aromatase | 0.391 |
| Antiviral | No |
| Prediction | 0.543519 |